Lucinda Tam Selected Research

Neoplasms (Cancer)

11/2022	LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity.
9/2022	Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.
4/2017	The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
1/2017	An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucinda Tam Research Topics

Disease

4	Neoplasms (Cancer) 11/2022 - 01/2017
3	Fibrosis (Cirrhosis) 01/2023 - 01/2022
3	Inflammation (Inflammations) 10/2022 - 04/2017
2	Pain (Aches) 01/2023 - 01/2021
2	Asthma (Bronchial Asthma) 10/2022 - 01/2021
1	Congenital Pain Insensitivity 01/2023
1	Idiopathic Pulmonary Fibrosis 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Breast Neoplasms (Breast Cancer) 09/2022
1	Hypersensitivity (Allergy) 09/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Cough 01/2021
1	Edema (Dropsy) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2013

Drug/Important Bio-Agent (IBA)

2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 04/2017
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Voltage-Gated Sodium ChannelsIBA 01/2023
1	CollagenIBA 01/2023
1	EnkephalinsIBA 01/2023
1	Leucine (L-Leucine)FDA Link 11/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	CytokinesIBA 10/2022
1	PeriostinIBA 10/2022
1	Neutralizing AntibodiesIBA 10/2022
1	Kallikreins (Kallikrein)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Estrogen Receptor alphaIBA 09/2022
1	Estrogen ReceptorsIBA 09/2022
1	Progesterone FDA LinkGeneric 09/2022
1	giredestrantIBA 09/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	myocardinIBA 01/2022
1	IntegrinsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	GDC-0334IBA 01/2021
1	Transient Receptor Potential ChannelsIBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2017
1	Phosphotransferases (Kinase)IBA 04/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2017
1	Mitogen-Activated Protein KinasesIBA 04/2017
1	Mitogen-Activated Protein Kinase 3IBA 04/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Bispecific AntibodiesIBA 01/2017
1	blinatumomabIBA 01/2017
1	Immunoglobulin G (IgG)IBA 03/2013
1	Cytidine DeaminaseIBA 03/2013
1	AntigensIBA 03/2013
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2013

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2021
1	Analgesia 01/2023
1	Lasers (Laser) 01/2023